当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
Nityr tablets
儿科标签批准日期
2020/9/2 0:00:00
特定指示/秒
Treatment of HT-1 in combination with dietary restriction of tyrosine and phenylalanine in adults and pediatric patients
标签更改摘要
- Safety and effectiveness have been established in pediatric patients for the treatment of HT-1 in combination with dietary restriction of tyrosine and phenylalanine.
- Use in pediatric patients is supported by evidence from one open-label, uncontrolled clinical study conducted with another oral formulation of nitisinone in 207 patients with HT-1 ages 0 to 22 years (median age 9 months)
- Information on dosing, maintenance regimen, PK parameters, and clinical trial
- New dosage regimen.